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ABSTRACT 
The TOR kinase integrates nutritional and stress signals to coordinately control cell 
growth in all eukaryotes.  TOR associates to highly conserved proteins to constitute two 
distinct signaling complexes termed TORC1 and TORC2.  Inactivation of TORC1 by 
rapamycin negatively regulates protein synthesis in most eukaryotes.  Here we report 
that downregulation of TOR signaling by rapamycin in the model green alga 
Chlamydomonas reinhardtii resulted in pronounced phosphorylation of the endoplasmic 
reticulum chaperone BiP.  Our results indicated that Chlamydomonas TOR regulates 
BiP phosphorylation through the control of protein synthesis since rapamycin and 
cycloheximide have similar effects on BiP modification and protein synthesis inhibition.  
Modification of BiP by phosphorylation was suppressed under conditions that require 
the chaperone activity of BiP such as heat shock stress or tunicamycin treatment, which 
inhibits N-linked glycosylation of nascent proteins in the endoplasmic reticulum.  A 
phosphopeptide localized in the substrate-binding domain of BiP was identified in 
Chlamydomonas cells treated with rapamycin.  This peptide contains a highly 
conserved threonine residue that might regulate BiP function as demonstrated by yeast 
functional assays.  Thus, our study has revealed a regulatory mechanism of BiP in 
Chlamydomonas by phosphorylation/dephosphorylation events and assigns a role to the 
TOR pathway in the control of BiP modification. 
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INTRODUCTION 
The abundance and quality of nutrients are key factors that determine cell growth 
(increase in cell mass) in all living organisms.  In eukaryotes, the availability of 
nutrients as well as other environmental cues is transmitted to the cell growth machinery 
through a number of important signalling proteins including the target of rapamycin 
(TOR) kinase (for reviews see (Crespo and Hall, 2002; De Virgilio and Loewith, 2006; 
Wullschleger et al., 2006; Ma and Blenis, 2009; Sengupta et al., 2010)).  TOR is a 
Ser/Thr kinase that associates to other proteins to form two distinct multiprotein 
complexes, termed TORC1 and TORC2, which modulate two major signalling branches 
in eukaryotic cells (Hara et al., 2002; Kim et al., 2002; Loewith et al., 2002; Wedaman 
et al., 2003; Jacinto et al., 2004).  TOR and other core components of these two 
complexes are evolutionarily conserved from lower to higher eukaryotes, indicating that 
these proteins must play central roles in nutrient signalling (Wullschleger et al., 2006). 
The TOR pathway stimulates cell growth by promoting anabolic processes, 
including translation and ribosome biogenesis, and inhibiting catabolic processes such 
as autophagy (Crespo and Hall, 2002).  Control of protein synthesis is one of the best-
characterized processes downstream of the TOR pathway.  In yeast and mammals, 
TORC1 controls protein synthesis at different levels by positively regulating translation 
initiation and ribosome biogenesis (De Virgilio and Loewith, 2006; Ma and Blenis, 
2009).  The function of a number of translation factors, including eIF4E, eIF4G and 
eIF2 are regulated by TORC1 signalling (Beretta et al., 1996; Redpath et al., 1996; 
Raught et al., 2000) whereas key proteins in promoting translation such as the 
mammalian S6K or yeast SCH9 AGC (protein kinase A/protein kinase G/protein kinase 
C-family) kinases are direct substrates of TORC1 (Pearson et al., 1995; Urban et al., 
2007).  Under favourable growth conditions, yeast TORC1 phosphorylates several 
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serine and threonine residues in the carboxy terminus of SCH9, and phosphorylated 
SCH9 participates in the activation of all three RNA polymerases (Urban et al., 2007).  
In mammalian cells, phosphorylated S6K promotes phosphorylation of the ribosomal 
protein S6, which in turn results in the up-regulation of translation initiation (Chung et 
al., 1992).  In addition to activating protein synthesis, TORC1 inhibits autophagy when 
nutrients are available (Noda and Ohsumi, 1998).  Autophagy is a membrane-trafficking 
process by which starved cells degrade and recycle cytosolic proteins and organelles.  
During this catabolic process, cytosolic components are nonselectively enclosed within 
a double-membrane structure (autophagosome) and delivered to the vacuole/lysosome 
for degradation (Xie and Klionsky, 2007; Nakatogawa et al., 2009).  TORC1 has been 
identified as an essential component in transmitting nutrient starvation signals to the 
autophagic machinery in yeast and higher eukaryotes.  TORC1 negatively controls 
autophagy via inhibition of the evolutionarily conserved protein kinase ATG1 that 
mediates an early activation step in the autophagic process (reviewed in (Diaz-Troya et 
al., 2008)). 
 The TOR kinase has been described in plants and algae, indicating that this 
signalling pathway is also conserved in photosynthetic organisms (Menand et al., 2002; 
Crespo et al., 2005).  In both systems, TOR has been involved in cell growth control, 
since disruption of the AtTOR gene in Arabidopsis thaliana is lethal (Menand et al., 
2002), and rapamycin-mediated inactivation of CrTOR in Chlamydomonas reinhardtii 
results in strong inhibition of cell growth (Crespo et al., 2005).  Components of TORC1 
signalling are conserved in Arabidopsis and Chlamydomonas. AtRaptor1 and 
AtRaptor2 have been described as homologues of KOG1/raptor in Arabidopsis 
(Anderson et al., 2005; Deprost et al., 2005), and direct interaction of AtRaptor1 with 
AtTOR has been demonstrated, indicating that TORC1 might be conserved in plants 
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(Mahfouz et al., 2006).  Besides KOG1/raptor and TOR proteins, two putative LST8 
homologues can be identified in the Arabidopsis genome (Moreau, 2010; Dobrenel et 
al., 2011).  In Chlamydomonas, it has been demonstrated that CrTOR localizes in high-
molecular-mass complexes that include a highly conserved LST8 homologue (Diaz-
Troya et al., 2008).  These findings indicate that TORC1 might be functionally and 
structurally conserved in photosynthetic eukaryotes.  However, no obvious homologues 
exist for TORC2-specific partners in plants or algae (Moreau, 2010; Pérez-Pérez, 2010; 
Dobrenel et al., 2011). 
 Dissection of the TOR pathway in plants has been hampered by the natural 
resistance of these organisms to rapamycin likely due to the inability of plant FKBP12 
to bind to this drug (Xu et al., 1998).  Nevertheless, the generation of inducible RNAi 
lines that allow conditional silencing of the AtTOR gene (Deprost et al., 2007) or 
rapamycin-sensitive plants (Sormani et al., 2007; Leiber et al., 2010) have importantly 
contributed to understand how TOR controls plant cell growth.  The finding that 
silencing of AtTOR expression arrests plant growth and reduces mRNA translation 
(Deprost et al., 2007) strongly suggests that control of protein synthesis by TOR is 
conserved in plants.  Unlike plants, Chlamydomonas is sensitive to rapamycin and 
inactivation of TOR signalling by this drug leads to cell growth inhibition (Crespo et al., 
2005) and autophagy activation (Perez-Perez and Crespo, 2010; Perez-Perez et al., 
2010), demonstrating that TOR controls this degradative process in photosynthetic 
organisms.  Recently, it has also been shown that TOR inhibits autophagy in plants (Liu 
and Bassham, 2010).  Like in other systems, the identification of components of the 
TOR pathway in plants and algae will be essential to understand how TOR controls cell 
growth in these organisms. 
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 In this study we show that the endoplasmic reticulum (ER) chaperone BiP 
becomes phosphorylated in Chlamydomonas cells treated with rapamycin.  BiP 
phosphorylation also occurred in response to inhibition of protein synthesis, whereas 
ER stress induced by tunicamycin or heat shock resulted in the complete 
dephosphorylation of the protein.  Our findings indicate that a rapamycin-sensitive TOR 
pathway controls the phosphorylation state of BiP in Chlamydomonas and reveals a 
conserved regulatory mechanism of this protein by phosphorylation/dephosphorylation 
events. 
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RESULTS 
Rapamycin treatment induces threonine phosphorylation of a 70 kDa protein 
In order to identify proteins regulated by TOR in Chlamydomonas and whose 
phosphorylation state is under the control of this signalling pathway, we performed 
western blot analysis of total extracts from Chlamydomonas cells treated with 
rapamycin using anti-phosphoserine (anti-P-Ser) and anti-phosphothreonine (anti-P-
Thr) antibodies.  Whereas no significant difference was observed in extracts from 
untreated cells compared to rapamycin-treated cells with the anti-P-Ser antibody, levels 
of Thr phosphorylation of a 70-kDa protein were increased, as detected with an anti-P-
Thr antibody (Figure 1A).  In order to resolve the 70 kDa molecular mass range, we 
conducted two-dimensional (2D) gel electrophoresis analysis of Chlamydomonas cells 
treated with rapamycin.  Total extracts obtained from rapamycin-treated or untreated 
cells were subjected to isoelectric focusing followed by SDS-PAGE and examined by 
Coomassie staining and western blot with the anti-P-Thr antibody (Figure 1B).  The 
comparative analysis of the different 2D gels obtained allowed us to identify a few spots 
in the 70 kDa region that become phosphorylated (Figures 1B and 1C).  Three spots 
whose mobility was altered by rapamycin treatment were detected in untreated cells by 
Coomassie staining (Figure 1C).  Accordingly, the signal obtained in this region with 
the anti-P-Thr antibody was more intense in rapamycin-treated cells, indicating the 
presence of phosphorylated proteins in at least some of these spots (Figure 1B).  
Proteins present in the selected spots from control and treated samples were identified 
by mass spectrometry.  Most of the spots included a mixture of three proteins that 
belong to the same category, namely HSP70B and the BiP1/BiP2 chaperones (Suppl. 
Table 1).  HSP70B and the two isoforms of the BiP chaperone are members of the 
HSP70 superfamily (Schroda, 2004) and have a molecular mass of about 72 kDa and 
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similar isoelectric points, which explains the co-migration in the same spots.  However, 
these proteins are localized in different compartments of the cell since HSP70B resides 
in the chloroplast while BiP1/2 proteins are predicted to be ER proteins (Schroda, 
2004). BiP1 and BiP2 share 90% identity at the amino acid level, and both proteins 
were present from spot 1’ to 5’ from rapamycin-treated cells (Figure 1C and Suppl. 
Table 1).  Given the high identity of BiP1 and BiP2, these proteins could not be 
differentially identified by available antibodies, and we will therefore refer to them as 
BiP chaperones.  In addition to the spots containing BiP and HSP70B proteins, other 
spots with reduced intensity were differentially detected in control and rapamycin-
treated samples with the anti-P-Thr antibody (Figure 1B).  Some new spots were found 
in response to rapamycin treatment, indicating that other proteins became 
phosphorylated upon TOR inactivation.  However, the identity of these proteins could 
not be verified. 
 
Identification of BiP chaperones as the phosphorylated proteins upon TOR 
inhibition 
The former experiments indicated that HSP70B and/or BiP might be modified 
by threonine phosphorylation in response to rapamycin-mediated inhibition of TOR 
signaling.  To investigate whether this post-translational modification is due to an 
increase of newly synthesized protein or an induction of protein phosphorylation, 
HSP70B and BiP levels were analyzed by western blot.  No significant accumulation of 
HSP70B or BiP chaperones was found after 8 hours of rapamycin addition to 
Chlamydomonas cultures, indicating that the signal detected by the anti-P-Thr antibody 
is due to an increase in protein phosphorylation (Figure 2A).  Furthermore, 
phosphorylation of HSP70B and/or BiP was not a rapid event since it occurred after 
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four to six hours of rapamycin addition (Figure 2A).  To demonstrate that this 
phosphorylation is specific to the inhibition of TOR signaling by rapamycin, we 
performed a similar experiment in the rapamycin resistant mutant rap2 that lacks the 
rapamycin primary target FKBP12 (Crespo et al., 2005).  As expected, no 
phosphorylation induction was found in this mutant in response to rapamycin (Figure 
2A). 
Next, we investigated if the signal detected with the anti-P-Thr antibody is 
caused by the modification of HSP70B and BiP chaperones or only by one of these 
proteins.  To this aim, we performed 2D gel electrophoresis followed by western blot 
analysis using antibodies specific to HSP70B or BiP.  Samples were separated in the 
first dimension by isoelectric focusing in pH 4-7 strips in order to obtain a better 
resolution of HSP70B and BiP spots.  The signal of the anti-P-Thr antibody was 
strongly induced in certain spots of rapamycin-treated cells (Figure 2B), indicating the 
modification of the protein(s) localized in these spots.  The mobility of the HSP70B 
chaperone was not altered in response to rapamycin, which strongly suggests that this 
protein is not responsible for the increased signal obtained with the anti-P-Thr antibody 
(Figure 2B).  We cannot exclude, however, the possibility that HSP70B is 
phosphorylated, although this unlikely phosphorylation should have no obvious effect 
on the migration of the protein.  In contrast to HSP70B, the mobility of BiP was clearly 
influenced by rapamycin since new spots were detected in the region where the 
phosphothreonine signal was induced (Figure 2B).  Therefore, our results indicated that 
treatment of Chlamydomonas cells with rapamycin results in phosphorylation of BiP 
chaperones. 
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Inhibition of protein synthesis by cycloheximide or rapamycin induces BiP 
phosphorylation 
It is well established that inactivation of TOR by rapamycin results among other 
effects in the inhibition of protein synthesis in most eukaryotes.  We therefore 
investigated a possible link of protein synthesis inhibition and BiP phosphorylation by 
treating Chlamydomonas cells with cycloheximide.  Western blot analysis using the 
anti-P-Thr antibody revealed that cycloheximide induced BiP phosphorylation even 
more efficiently than rapamycin since phosphorylation was detected within one hour of 
treatment (Figure 3A).  Addition of cycloheximide and rapamycin simultaneously did 
not result in a more pronounced phosphorylation of BiP, suggesting that both drugs act 
on the same pathway. 
These results indicate that BiP phosphorylation may be induced as a result of 
protein synthesis inhibition mediated by rapamycin or cycloheximide.  To test this 
hypothesis, we investigated if rapamycin has a negative effect on translation, as 
described in other eukaryotes.  Chlamydomonas cultures were treated with rapamycin 
and protein synthesis was examined in vivo by labelling cells with [14C]arginine.  
Rapamycin-mediated inhibition of TOR resulted in a 30-40% reduction in protein 
synthesis, demonstrating that indeed TOR promotes translation in Chlamydomonas 
(Figure 3B).  Similar experiments were conducted with cycloheximide instead of 
rapamycin and about 90% of protein synthesis was inhibited (Figure 3B).  The 
specificity of rapamycin on translation inhibition was confirmed by the nule effect of 
the drug in the rap2 mutant (Figure 3B).  A time-course experiment revealed that 
cycloheximide and rapamycin have different kinetics in inhibiting protein synthesis 
since cycloheximide quickly and efficiently reduced the incorporation of [14C]arginine 
into proteins while rapamycin caused a progressive and less intense effect (Figure 3C), 
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in agreement with the faster phosphorylation of BiP detected with cycloheximide 
compared to rapamycin treatments (Figure 3A).  Thus, our results strongly suggest that 
BiP phosphorylation occurred primarily in response to a decrease in the rate of protein 
synthesis. 
 
Dephosphorylation of BiP correlates with chaperone activation 
In general, chaperone activity of BiP is up-regulated under stress conditions that 
increase the level of misfolded proteins in the ER (Otero et al., 2010).  Stress-induced 
activation of BiP has been correlated with in vivo dephosphorylation of the protein in 
mammalian cells (Hendershot et al., 1988; Freiden et al., 1992; Satoh et al., 1993).  To 
investigate whether threonine phosphorylation of BiP detected in Chlamydomonas is 
related with a regulatory mechanism of this protein, Chlamydomonas cells were 
subjected to heat stress and the phosphorylation state of BiP was examined.  Basal 
phosphorylation level of BiP was strongly reduced within 15 min of heat shock, being 
undetectable after 60 min (Figure 4A).  2D gel electrophoresis analysis of heat shocked 
cells further confirmed that this stress caused the complete dephosphorylation of all 
spots initially detected in untreated cells with the anti-P-Thr antibody (Figure 2B).  
Dephosphorylation of BiP by heat shock was also determined in cells that have been 
previously treated with rapamycin to increase the phosphorylation level of BiP prior to 
heat stress.  Heat shock also resulted in undetectable levels of BiP phosphorylation 
despite the elevated modification of the chaperone after rapamycin treatment (Figure 
4B).  These results indicated that BiP is dephosphorylated upon heat shock likely due to 
increased levels of unfolded polypeptides in the ER. 
To strengthen this model, a specific stress in the ER was generated by treating 
cells with tunicamycin, which inhibits N-linked glycosylation of nascent proteins at this 
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compartment, and the phosphorylation state of BiP was examined by western blot.  
Compared to untreated cells, tunicamycin abolished the basal level of BiP 
phosphorylation (Figure 4C, compare lanes 6 and 7 with lanes 2 and 3).  In addition to 
the effect of tunicamycin on basal BiP phosphorylation, we investigated whether 
tunicamycin may induce dephosphorylation of BiP under conditions where BiP is 
strongly phosphorylated.  As described above, Chlamydomonas cells were first treated 
with rapamycin to induce BiP phosphorylation and then with tunicamycin without 
removing rapamycin from the medium.  The phosphorylation state of BiP was elevated 
at the time of tunicamycin addition (Figure 4C, compare lane 8 to lane 2).  Tunicamycin 
reduced BiP phosphorylation to undetectable levels in rapamycin-treated cells (Figure 
4C, compare lane 9 to lane 5).  Based on these results, tunicamycin treatment must 
activate BiP in the ER.  Taken together, these results indicated that phosphorylation of 
BiP is strongly reduced under conditions that induce stress in the ER and consequently 
require the activity of this chaperone at this cellular compartment. 
 
The highly conserved Thr520 plays a role in BiP function 
To further characterize the modification of BiP, we tried to identify rapamycin-
sensitive phosphorylation sites by mass spectrometry (MS).  Total extracts from 
untreated or rapamycin-treated cells were resolved by 2D gel electrophoresis and BiP 
proteins were excised from the gel, digested with the endoproteinase GluC and analyzed 
by MS for phosphopeptide identification (see Materials and Methods).  A 
phosphopeptide containing a single phosphate was identified in BiP samples from 
rapamycin-treated cells.  This phosphopeptide was not detected in BiP samples prepared 
from untreated cells.  The phosphopeptide is localized in a highly conserved region of 
the substrate-binding domain of BiP and extended from Glu504 to Lys525 of BiP1 
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(Figure 5A).  An alignment of BiP proteins from different organisms revealed that a 
threonine residue (Thr520 in Chlamydomonas BiP1) from this phosphopeptide is 
widely conserved within eukaryotes (Figure 5B).  Interestingly, a modelling study of 
BiP1 indicated that Thr520 might be in an exposed region of the chaperone accessible 
to other proteins (Figure 5C) while the NetPhosK server (Blom et al., 2004) predicted 
Thr520 as the residue with the highest probability of phosphorylation in BiP1.  Our 
results therefore indicated that inhibition of TOR signalling by rapamycin leads to 
phosphorylation of BiP in a conserved region of the peptide-binding domain and 
strongly suggested that Thr520 might play an important role in this modification. 
To explore this hypothesis, we performed a functional study of Chlamydomonas 
BiP1 in yeast where conditional BiP mutants have been previously reported (Vogel et 
al., 1990).  Although KAR2 (yeast BiP) is an essential gene (Normington et al., 1989; 
Rose et al., 1989), temperature sensitive (ts) mutants have been generated.  The kar2-
159 mutation was isolated in a genetic screen of ts alleles of KAR2 and allows growth at 
23°C but not at 35-37°C (Vogel et al., 1990).  Wild type and kar2-159 mutant cells were 
transformed with a plasmid expressing the Chlamydomonas BiP1 cDNA from the 
strong, constitutive GPD promoter (see Materials and Methods for details).  Yeast 
complementation assays indicated that while kar2-159 cells transformed with an empty 
vector were not able to grow at the restrictive temperature of 37°C, expression of 
Chlamydomonas BiP1 partially corrected the growth defect of kar2-159 cells at 30°C 
but not at 37ºC (Figure 6A).  Moreover, BiP1 was not able to functionally replace yeast 
KAR2 in a heterozygous Δkar2 mutant strain (Suppl. Fig. 1).  Western blot analysis of 
these strains confirmed that BiP1 is expressed in kar2-159 cells although to a lower 
level than in Chlamydomonas cells (Figure 6B).  Compared to Chlamydomonas 
extracts, most of the BiP1 protein expressed in yeast was detected as a band of higher 
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molecular mass (Figure 6B).  It is well established that KAR2 is itself translocated into 
the ER in yeast via a mechanism that depends on KAR2 function, and mature and 
precursor forms of the protein can be detected under certain circumstances (Rose et al., 
1989; Vogel et al., 1990).  Therefore, the lower mobility band of BiP1 might very likely 
correspond to the precursor form of the protein that cannot be properly translocated into 
the ER. 
With the availability of a functional assay for Chlamydomonas BiP1, we next 
investigated whether the conserved Thr520 of this protein is involved in BiP function.  
Thr520 was replaced by Ala, Glu or Arg, and the point mutants (T520A, T520E and 
T520R, respectively) were expressed in yeast cells.  Similar to wild-type BiP1, T520A 
and T520R proteins were able to promote growth of kar2-159 cells at 30ºC (Figure 6A).  
However, T520E mutation, which mimics a constitutive phosphorylation of the residue, 
could not fully complement BiP function at 30ºC, indicating that T520E mutation 
decreased BiP function (Figure 6A).  None of the BiP1 mutants were able to promote 
growth at 37ºC (Figure 6A).  Interestingly, all mutations in Thr520 resulted in a 
pronounced increase in the abundance of the precursor and mature forms of this protein 
in yeast cells compared to wild-type BiP1 (Figure 6B), which indicates that this residue 
is important for the stability and processing of BiP1 in yeast cells. 
 
Cellular relocalization of BiP upon ER stress induced by tunicamycin 
BiP has been localized in Chlamydomonas to discrete punctae all over the cell 
that are more abundant around the flagellar basal bodies ((Diaz-Troya et al., 2008) and 
Figure 7), a membrane-enriched region known as peri-basal body region where 
intraflagellar transport (IFT) particle polypeptides concentrate (Cole et al., 1998).  We 
wanted to investigate whether phosphorylation/dephosphorylation events of BiP might 
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result in alterations in the cellular localization pattern of this protein.  Compared to 
control cells, no difference was observed in cells where BiP phosphorylation was 
induced by rapamycin (Figure 7).  However, tunicamycin-mediated dephosphorylation 
of BiP resulted in a relocalization of this protein in the cell, being accumulated in a 
central region of the cell near the nucleus instead of the distal peri-basal body region 
(Figure 7).  The cellular distribution of BiP in cells subjected to heat shock did not 
significantly differ from untreated cells (data not shown).  These results demonstrate 
that dephosphorylation and activation of BiP by a specific stress in the ER correlates 
with a mobilization and concentration of this protein to this cellular compartment, and 
may reflect the requirement of dephosphorylated BiP to overcome this stress. 
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DISCUSSION 
We have previously reported that, unlike plants, growth of Chlamydomonas 
cells is sensitive to rapamycin, indicating that a rapamycin-sensitive TOR pathway 
operates in this unicellular green alga to govern cell growth (Crespo et al., 2005; Diaz-
Troya et al., 2008).  In this study we show that inactivation of TOR signalling by 
rapamycin caused inhibition of protein synthesis in Chlamydomonas (Figure 3B), which 
demonstrates that TOR promotes protein synthesis in this photosynthetic organism.  
Control of protein synthesis by TOR has been widely characterized in yeast and 
mammalian cells.  In these systems, inhibition of TORC1 signalling by rapamycin 
resulted in a decrease in protein synthesis (Barbet et al., 1996; Beretta et al., 1996; 
Loewith et al., 2002).  In Arabidopsis, inducible RNAi of the AtTOR gene or rapamycin 
treatment of plant lines expressing yeast FKBP12 caused a reduction in the abundance 
of high-molecular weight polysomes (Deprost et al., 2007; Sormani et al., 2007), 
indicating that TOR also controls protein translation in plants likely through a 
conserved TORC1 signaling branch since core components of this complex are 
conserved (Anderson et al., 2005; Deprost et al., 2005; Mahfouz et al., 2006). 
Our analysis of rapamycin-treated cells identified the ER chaperone BiP as a 
phosphoprotein whose phosphorylation state is regulated by TOR through the control of 
protein synthesis in Chlamydomonas.  Inhibition of TOR signalling by rapamycin 
strongly induced phosphorylation of BiP on threonine residues (Figures 1 and 2) and a 
phosphopeptide in a regulatory region of BiP that contains a highly conserved threonine 
(Thr520) could be identified in rapamycin-treated cells (Figure 5).  Although our study 
identified a single phosphopeptide in this chaperone, we cannot rule out that other 
residues might be phosphorylated as well.  Actually, our results indicate that rapamycin 
further induced a basal, low level of phosphorylation in BiP, suggesting the presence of 
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additional phosphorylation sites (Figures 1 to 4).  Post-translational modification of BiP, 
including phosphorylation and ADP-ribosylation, has been previously reported in 
mammalian cells (Carlsson and Lazarides, 1983; Welch et al., 1983; Hendershot et al., 
1988; Freiden et al., 1992).  Phosphoamino acid analysis of purified mammalian BiP 
demonstrated that this protein is predominantly phosphorylated on threonine residues 
with only a trace of detectable phosphoserine (Hendershot et al., 1988; Gaut, 1997).  
Moreover, in vivo threonine phosphorylation has been mapped to a region of the 
peptide-binding domain of mammalian BiP (Gaut, 1997) adjacent to the phosphopeptide 
identified in Chlamydomonas BiP (Figure 5). 
Modification of mammalian BiP by phosphorylation or ADP-ribosylation seems 
to be restricted to a pool of BiP that does not bind to substrate proteins (Hendershot et 
al., 1988; Freiden et al., 1992).  Furthermore, it has been demonstrated that stresses 
which increase the need for active BiP in mammalian cells such as glucose starvation or 
tunicamycin treatment promote dephosphorylation of BiP and its association with 
proteins (Hendershot et al., 1988; Satoh et al., 1993).  These findings led to the theory 
that modified BiP represents an inactive form of the protein, and that unmodified BiP is 
able to bind to proteins and promote their folding and assembly (Hendershot et al., 
1988).  It has been also proposed that post-translational modification of BiP might 
provide a storage pool of BiP that can be recruited back to the active form in response to 
need (Gething, 1999).  The present study strongly suggests that regulation of BiP by 
phosphorylation is conserved in the photosynthetic alga Chlamydomonas, and assigns a 
novel role to the TOR pathway in the control of BiP phosphorylation.  Similar to 
rapamycin, treatment of Chlamydomonas cells with cycloheximide resulted in increased 
phosphorylation of BiP (Figure 3).  Both drugs have a negative effect on protein 
synthesis although with different efficiencies since cycloheximide is more effective than 
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rapamycin in translation inhibition (Figure 3).  Interestingly, BiP phosphorylation 
occurred faster in response to cycloheximide since phosphorylated BiP was detected 
within one hour in cycloheximide-treated cells whereas rapamycin induced BiP 
phosphorylation after at least four hours (Figure 3).  Thus our results establish a 
correlation between phosphorylation of BiP and protein synthesis through the TOR 
pathway in Chlamydomonas. 
Supporting the model that unmodified BiP is active (Hendershot et al., 1988), we 
found in Chlamydomonas that stress conditions that require the chaperone activity of 
BiP such as heat shock or inhibition of protein glycosylation in the ER by tunicamycin, 
triggered the fast dephosphorylation of BiP (Figure 4).  Moreover, complete BiP 
dephosphorylation in response to heat shock or tunicamycin occurred even in cells 
where BiP phosphorylation was previously induced by inhibition of TOR signalling, 
emphasising the linkage between dephosphorylation and activation of BiP.  Our results 
also demonstrated that the cellular localization of BiP is regulated by the 
phosphorylation state of the protein.  Tunicamycin-induced dephosphorylation and 
activation of BiP clearly modified the cellular distribution of this chaperone in the cell 
as it accumulated in a central region of the cell near the nucleus where ER and Golgi 
compartments likely localize (Figure 7).  Our findings in Chlamydomonas indicated that 
modification of BiP by phosphorylation/dephosphorylation events may play a 
regulatory role in the function of this chaperone, and that this molecular mechanism of 
regulation proposed in mammals (Hendershot et al., 1988; Freiden et al., 1992; Satoh et 
al., 1993) is conserved in photosynthetic eukaryotes.  In vivo phosphorylation of BiP 
has been described in maize (Fontes et al., 1991) and spinach (Anderson et al., 1994), 
although to our knowledge a link between the phosphorylation state of the protein and 
its activity has not been shown in plants. 
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Yeast complementation assays performed with Chlamydomonas BiP1 indicated 
that this protein is able to replace only partially endogenous KAR2 function (Figure 6) 
despite the high identity between both proteins.  Functional complementation of kar2 
mutants has been achieved with mammalian and plant BiP proteins (Normington et al., 
1989; Denecke et al., 1991).  However, neither cytosolic nor mitochondrial yeast 
HSP70s are able to substitute functionally for KAR2 (Brodsky et al., 1993; Brodsky et 
al., 1998) likely due to the inability of these proteins to productively interact with 
proteins such as cochaperones or components of the ER translocation machine.  The 
partial complementation of kar2-159 mutant cells by Chlamydomonas BiP1 might be 
due to an ineffective interaction of this protein to substrates or specific partners.  
Accordingly, most Chlamydomonas BiP1 was detected in yeast extracts as a precursor 
form, indicating that, unlike endogenous KAR2 (Rose et al., 1989; Vogel et al., 1990), 
this protein is not efficiently translocated into the ER lumen.  Mutation of the conserved 
Thr520 in BiP1 led to a reduction in protein function (Figure 6A).  These results suggest 
that this residue plays a role in the control of BiP1 activity in yeast cells and are in 
agreement with the finding that threonine phosphorylation inhibits BiP activity in 
mammals (Hendershot et al., 1988; Satoh et al., 1993; Gaut, 1997).  Given that 
phosphorylation maps to the peptide-binding domain, this modification might interfere 
with substrate binding and/or interaction with partners such as cochaperones, as 
proposed for mammalian BiP (Gaut, 1997).  The finding that Thr520 mutation in 
Chlamydomonas BiP1 stimulated maturation of this protein in yeast cells indicated that 
this residue is indeed important for the regulation of BiP1. 
Biochemical fractionation and indirect immunofluorescence microscopy studies 
revealed that TOR complexes in Chlamydomonas might associate, at least in part, with 
membranes from the ER (Diaz-Troya et al., 2008).  Actually, the cellular distribution of 
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Chlamydomonas TOR and BiP proteins was coincident in some aspects.  Both proteins 
localize to discrete bodies and accumulate in the peri-basal body region ((Diaz-Troya et 
al., 2008) and Figure 7).  The common distribution of TOR and ER proteins may reflect 
functional interactions between the TOR pathway and this cellular compartment in 
Chlamydomonas.  Several lines of evidence have recently associated TOR signalling 
and ER stress in mammals.  Loss of the tuberous sclerosis (TSC) tumor suppressor 
complex, an upstream negative regulator of mTORC1 (Garami et al., 2003; Saucedo et 
al., 2003; Tee et al., 2003; Zhang et al., 2003), causes increased translation in certain 
mouse or human tumors due to the up-regulation of mTORC1 signalling, which in turn 
induces ER stress (Ozcan et al., 2008).  This finding also indicates that mTORC1 
genetically functions upstream of ER stress (Ozcan et al., 2008).  Interestingly, it has 
been reported that the accumulation of misfolded proteins in mice induces mTORC1 
signalling, which is directly regulated by chaperone availability (Qian et al., 2010).  
These studies have revealed the important role that control of protein synthesis by 
TORC1 plays on the regulation of ER homeostasis.  Components of TORC1 signaling 
controlling protein synthesis such as raptor or the S6 kinase are conserved in plants and 
seem to participate in the general response of the plant to osmotic stress signals 
(Mahfouz et al., 2006; Deprost et al., 2007).  However, it remains to be explored if, like 
in Chlamydomonas, TOR may function in ER stress through the control of protein 
synthesis. 
In conclusion, our studies show that the ER chaperone BiP can be regulated by 
reversible phosphorylation in Chlamydomonas and connect TOR signalling to this 
process.  A better understanding of BiP regulation by phosphorylation/ 
dephosphorylation events will come with the identification of kinases and phosphatases 
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involved in the post-translational modification of this chaperone and their possible 
control by TOR and/or other signalling pathways. 
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MATERIALS AND METHODS 
Strains and Growth Conditions 
Chlamydomonas reinhardtii wild-type strain 6C+ was obtained from the 
laboratory of J.-D. Rochaix (University of Geneva), and rapamycin-insensitive rap2 
strain has been previously described (Crespo et al., 2005).  Cells were grown as 
described by Harris (1989) under continuous illumination at 25ºC. If required, Tris-
acetate phosphate medium (TAP) was solidified with 1.2% Bacto agar (Difco).  When 
specified, cells were treated with 500 nM rapamycin (LC Labs) from a 4 mM stock in 
90% ethanol-10% Tween20, 5 μg/ml tunicamycin (Calbiochem) from a 5 mg/ml stock 
in dimethylformamide, or 10 μg/ml cycloheximide (Sigma) from a 3 mg/ml stock in 
water.  Saccharomyces cerevisiae wild-type (MS10) and kar2-159 were obtained from 
the laboratory of M. D. Rose.  YJL034W (KAR2) heterozygous mutant was obtained 
from the EUROSCARF mutant collection.  Yeast cells were grown in rich or synthetic 
medium as previously described (Sherman, 1991). 
 
Protein preparation 
Chlamydomonas cells from liquid cultures were collected by centrifugation 
(3000 x g, 5 min), washed once in lysis buffer (50 mM Tris-HCl (pH 7.5), 10 mM NaF, 
10 mM NaN3, 10 mM p-Nitrophenylphosphate, 10 mM NaPPi, 10 mM beta-
glycerophosphate), and resuspended in a minimal volume of the same solution 
supplemented with Protease Inhibitor Cocktail (Sigma).  Cells were lysed by two cycles 
of slow freezing to -80ºC followed by thawing to room temperature. The soluble cell 
extract was separated from the insoluble fraction by centrifugation (15700 x g, 15 min) 
at 4ºC, and stored at -80ºC until they were analyzed.  Yeast extracts from 
logarithmically growing cells were prepared in lysis buffer (PBS buffer, 1 mM PMSF, 
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0.5% Tween20, 10 mM NaF, 10 mM NaN3, 10 mM p-Nitrophenylphosphate, 10 mM 
NaPPi, 10 mM beta-glycerophosphate) by vortexing them 10 times for 1 min each time 
with glass beads (Sigma-Aldrich).  Crude extracts were cleared by centrifugation at 
15,000g for 15 min at 4_C.  Proteins were quantitated with the Coomassie dye binding 
method (BioRad).   
 
2D gel electrophoresis 
For 2D electrophoresis, proteins from soluble cell extract samples were 
precipitated with 2D Clean-Up Kit (GE Healthcare), resuspended in rehydration 
solution, and quantitated with RC DC Protein Assay (BioRad) according to the 
manufacturers’ instruction.  Isoelectric focusing (IEF) for the first dimension was 
carried out by rehydrating 11 cm long pH 3-10NL or pH 4-7 Immobiline DryStrips (GE 
Healthcare) with 200 μl of DeStreak Rehydration Solution (GE Healthcare) 
supplemented with 0,5% Bio-Lyte 3/10 Ampholytes (BioRad) containing 150 μg of 
protein. Following overnight active rehydration (50V, 20°C), IEF was performed for 
15kVh (for pH 3-10NL strips) or 20kVh (for pH 4-7 strips) at 20°C using the Protean 
IEF Cell (Bio-Rad). After the first dimension separation, strips were blotted to remove 
mineral oil and stored at -80°C. Prior to the second dimension separation (SDS-PAGE), 
thawed strips were first equilibrated with 10 mg/ml DTT in equilibration buffer (6 M 
urea, 75 mM Tris-HCl pH 8.8, 29,3% glycerol, 2% SDS, and 0.002% bromophenol 
blue), and then with 25 mg/ml iodoacetamide in equilibration buffer. A RE 600 Ruby 
chamber system (GE Healthcare) was used for the second dimension separation. 
Equilibrated strips were placed on 10% SDS-PAGE gels and sealed with 0.5% agarose. 
Proteins were separated by molecular weight using a 70 mA constant intensity. Gels 
were Coomassie blue stained or processed for western blot. 
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Western blotting 
Proteins resolved by SDS-PAGE or 2D-gel electrophoresis were transferred to 
PVDF membrane (for phosphothreonine detection) or nitrocellulose membrane (for 
BiP, HSP70B and FKBP12 detection) for antibody binding.  Immunoblots were 
visualized using horseradish peroxidase-conjugated secondary antibodies (Sigma) and 
the ECL Plus chemiluminescent system (GE Healthcare). The Chlamydomonas 
FKBP12 polyclonal antibody has been described previously (Crespo et al., 2005).  The 
Arabidopsis BiP, Chlamydomonas HSP70-B, and phosphothreonine polyclonal 
antibodies were purchased from Santa Cruz Biotechnology, Agrisera, and Zymed 
Laboratories, respectively.  The KAR2 antibody was obtained from Santa Cruz 
Biotechnology. 
 
Fluorescence Microscopy 
Wild-type Chlamydomonas cells were fixed and stained for IF microscopy as 
described previously (Perez-Perez et al., 2010).  The primary antibody used was rabbit 
polyclonal anti-BiP (1:500; Santa Cruz Biotechnology).  For signal detection, a 
fluorescein isothiocyanate (FITC)-labelled goat anti-rabbit antibody (1:500; Sigma) was 
used.  Preparations were photographed on a DM6000B microscope (Leica) with an 
ORCA-ER camera (Hamamatsu) and processed with the Leica Application Suite 
Advanced Fluorescence software package (Leica).  Deconvolution analysis of images 
was performed with the same software. 
 
Protein identification by MALDI-TOF 
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CBB-stained proteins were excised from the gel using the EXQuest Spot Cutter 
excision robot (BioRad) and in-gel trypsin digested using a Proteineer dp Digester 
(Bruker Daltonics).  Gel plugs were incubated in acetonitrile (50 µl), and treated with 
10 mM DTT in 50 mM ammonium bicarbonate followed by 55 mM iodoacetamide in 
50 mM ammonium bicarbonate.  Trypsin digestion was performed at 30°C for 4 h using 
13 μg/ml trypsin in 50 mM ammonium bicarbonate.  Digestion was stopped and 
peptides extracted using 0.5% trifluoroacetic acid.  Tryptic digests were analysed using 
an Autoflex MALDI-TOF instrument (Bruker Daltonics, Billerica, MA, USA) and 
proteins were identified as the highest ranked result by searching the NCBI non-
redundant database, version from February 2008, for Viridiplantae (Green Plants) 
sequences (from a total of 474525 sequences) by the Protein Mass Fingerprint technique 
using the MASCOT search tool (Matrix Science; http://matrixscience.com).  The search 
parameters included carbamidomethylation of cysteines, oxidation of methionines, one 
miscleavage by trypsin and 50 ppm mass accuracy. 
 
Identification of phosphorylated peptides by MS 
To identify phosphorylated peptides, the gel slice containing BiP was reduced 
with 10 mM TCEP at 37oC for 1 hour and alkylated with 50 mM iodoacetamide for 15 
min at room temperature.  In-gel digestion was with 250 ng trypsin or 250 ng 
endoproteinase GluC at 37oC overnight.  The peptides were analyzed on an LTQ 
Orbitrap instrument (Thermo Fisher, San José, CA, USA) coupled to an Agilent 1200 
nano pump.  The solvents used for peptide separation were 0.1% acetic acid in water 
(solvent A) and 0.1% acetic acid and 80% acetonitrile in water (solvent B).  Peptides 
were injected via a 2 μl loop onto a C18 trap column (0.15 x 10 mm, SGE Analytical 
Science, Victoria, AU) with the capillary pump of an Agilent 1200 system set to 5 
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μl/min.  After 15 min, the trap column was switched into the flow path of the C18 
separating column (0.1 x 150 mm, Swiss Bioanalytics, Birsfelden, CH).  A linear 
gradient from 2 to 35% solvent B in solvent A in 60 min was delivered with an Agilent 
1200 nano pump at a flow rate of 300 nl/min.  After 60 min the percentage of solvent B 
was increased to 60% in ten minutes and further increased to 80% within 2 min.  The 
eluting peptides were ionized at 1.7 kV.  The mass spectrometer was operated in a data-
dependent fashion.  The precursor scan was done in the Orbitrap set to 60,000 
resolution, while the fragment ions were mass analyzed in the LTQ instrument.  A top 
five method was run so that the five most intense precursors were selected for 
fragmentation.  The MS/MS spectra were then searched against the NCBI non-
redundant database, version from August 2008, using TurboSequest software (Gatlin et 
al., 2000).  The databank was searched with Bioworks version 3.3.1. SP1 by setting the 
precursor ion tolerance to 10 ppm, while the fragment ion tolerance was set to 0.5 Da.  
Cleavage rules were set to Fully enzymatic – cleaves at both ends, allowing 2 missed 
cleavages.  The modifications were set to carbamidomethyl cysteine as fixed 
modification, while phosphorylation on Ser/Thr, and Tyr was set to variable 
modifications.  Post filtering was set to the following parameters: ΔCN, 0.1; Xcorr 
versus charge state was 1.50 (1+), 2.00 (2+), 2.50 (3+); peptide probability, 0.01; 
protein probability 0.01. 
 
Cloning of Chlamydomonas BiP1 and plasmid construction 
The BiP1 coding region from Chlamydomonas (1971 bp) was amplified by PCR 
from a Chlamydomonas cDNA library using the following primers: BiP1 SpeI 5’ (5’-
CCGGACTAGTATGGCGCAGTGGAAGGCTGCTGTGCTG-3’) and BiP1 SpeI 3’ 
(5’-CCGGACTAGTTTAGAGCTCGTCGTGGTCGCCCAAGTC-3’), designed to 
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contain a SpeI site (underlined).  The resulting product was digested with SpeI and 
inserted into p425GPD (Mumberg et al., 1995) for expression in S. cerevisiae.  The 
point mutations in Thr520 of BiP1, denoted as T520A, T520E and T520R, were 
obtained by overlapping PCR using the wild-type version of BiP1 and the following 
primers: T520A 5’ (5’-
GCCGCTGAGGACAAGGGCGCCGGCAAGAAGGAGAAGATC-3’), T520A 3’ (5’-
GATCTTCTCCTTCTTGCCGGCGCCCTTGTCCTCAGCGGC-3’), T520E 5’ (5’- 
GCCGCTGAGGACAAGGGCGAGGGCAAGAAGGAGAAGATC-3’), T520E 3’ (5’- 
GATCTTCTCCTTCTTGCCCTCGCCCTTGTCCTCAGCGGC-3’), T520R 5’ (5’- 
GCCGCTGAGGACAAGGGCCGCGGCAAGAAGGAGAAGATC-3’) and T520R 3’ 
(5’- GATCTTCTCCTTCTTGCCGCGGCCCTTGTCCTCAGCGGC-3’).  The final 
PCR products were cloned into p425GPD for expression in yeast cells. 
 
Labelling of cells with [14C]arginine 
Cell labelling was performed essentially as described in Stavis and Hirschberg 
(Stavis and Hirschberg, 1973) with some modifications.  Chlamydomonas cells from 
liquid TAP cultures at a density of 106 cells/ml were harvested by centrifugation (3000 
x g, 5 min), washed with TAP-N medium and cultured in the same medium for 6 h to 
improve [14C]arginine incorporation.  Next, cells were treated with 500nM rapamycin 
for 6h, 10 μg/ml cycloheximide for 30 min or drug vehicle.  Reactions mixtures 
containing 107 cells and 1 μCi [14C]arginine in 1 ml of medium were incubated at 25°C 
in the light with gentle shaking.  Samples of 0.1 ml were collected and added to 0.5 ml 
of cold 10% trichloroacetic acid (TCA).  The precipitated material was collected on 
Whatman glass fiber filters, washed four times with cold 5% TCA, dried, and 
radioactivity measured by a liquid scintillation counter. 
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FIGURE LEGENDS 
Figure 1. Rapamycin treatment induces alterations on the threonine phosphorylation 
pattern in Chlamydomonas soluble extract.  A, Western blot analysis of 
Chlamydomonas soluble extracts with phosphoserine (P-Ser) and phosphothreonine (P-
Thr) antibodies.  Log-phase wild-type cells were treated with 500 nM rapamycin (rap) 
or drug vehicle and samples were taken at the indicated times. Soluble extracts were 
fractionated by SDS-PAGE and analyzed by western blot.  The asterisk denotes the 70 
kDa band detected with the P-Thr antibody.  B, Soluble extracts of Chlamydomonas 
cells treated (rap) or not (control) with 500 nM rapamycin for 8 hours were resolved by 
2D electrophoresis as described in Experimental Procedures.  Gels were stained with 
Coomassie Brilliant Blue (CBB) or processed for immunodetection with the 
phosphothreonine (P-Thr) antibody.  C, Enlarged images of box sections in 2D gels 
shown in panel B.  Arrow indicates spots whose mobility differs in untreated and 
rapamycin-treated cells.  Numbers refer to spots where proteins have been identified by 
mass spectrometry (see Suppl. Table I for details). 
 
Figure 2. Rapamycin induces threonine phosphorylation of the BiP chaperone in its 
peptide-binding domain.  A, Phosphorylation time course of the 70 kDa protein 
following rapamycin treatment.  500 nM rapamycin or drug vehicle were added to wild-
type (wt) or rapamycin-insensitive (rap2) Chlamydomonas cells and samples were 
collected at the indicated times.  Soluble extracts were fractionated by SDS-PAGE and 
analyzed by western blotting probing with phosphothreonine (P-Thr), BiP and HSP70B 
specific antibodies. B, 2D western blot analysis of BiP and HSP70B.  Wild type 
Chlamydomonas cells were treated with 500 nM rapamycin for 12 hours (rap), heat 
shocked at 40ºC for 1 hour (HS) or remained untreated (control).  Soluble extracts were 
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resolved by 2D electrophoresis as described in Experimental Procedures using pH 4-7 
strips and gels were processed for immunodetection with phosphothreonine (P-Thr), 
BiP and HSP70B specific antibodies. 
 
Figure 3.  Inhibition of protein synthesis by rapamycin or cycloheximide induces BiP 
phosphorylation.  A, Time course of BiP phosphorylation following rapamycin and/or 
cycloheximide treatment.  500 mM rapamycin (rap), 10 μg/ml cycloheximide (CHX) or 
both drugs simultaneously (CHX + rap) were added to wild-type Chlamydomonas cells 
and samples were taken at the indicated times.  Soluble extracts were fractionated by 
SDS-PAGE and analyzed by western blot probing with P-Thr or BiP specific 
antibodies.  B, Incorporation of [14C]arginine in Chlamydomonas cells.  Wild-type (wt) 
and rapamycin-insensitive (rap2) Chlamydomonas cells were treated with 500nM 
rapamycin for 6 hours (rap), 10 μg/ml cycloheximide for 30 min (CHX), or drug vehicle 
(C) and processed for the analysis of [14C]arginine incorporation as described in 
Experimental Procedures.  Values are represented in relation to the [14C]arginine 
incorporation detected in control, untreated cells and correspond to six independent 
determinations (*p<0.05, **p<0.01).  C, Effect of CHX and rapamycin on protein 
synthesis.  Chlamydomonas cultures were treated with 500 nM rapamycin (triangles) or 
10 μg/ml CHX (circles) or drug vehicle (squares) and samples were taken at different 
times for protein synthesis determination.  Data correspond to results from three 
independent experiments made in duplicate. 
 
Figure 4.  BiP dephosphorylation by ER stress-inducing agents.  BiP dephosphorylation 
by heat stress.  Chlamydomonas cells pretreated (B) or not (A) with 500 nM rapamycin 
(rap) for 12 hours were subjected to heat stress at 40ºC and samples were taken at the 
 37
indicated times.  Soluble extracts were fractionated by SDS-PAGE and analyzed by 
western blot probing with P-Thr and BiP specific antibodies.  C, BiP dephosphorylation 
by tunicamycin treatment.  Chlamydomonas cells were treated with 500 nM rapamycin 
(rap), 5 μg/ml tunicamycin (tun), or first treated with rapamycin (rap, lane 8) and then 
with tunicamycin (rap tun, lane 9). Samples were taken at the indicated times and 
soluble extracts were processed and analyzed by western blot. 
 
Figure 5.  Identification of a phosphopeptide in Chlamydomonas BiP.  A, Schematic 
representation of the BiP protein and identification of a phosphopeptide in the peptide-
binding domain.  The scheme shows the ATPase and peptide-binding domains of BiP.  
The position of the phosphopeptide identified in Chlamydomonas is indicated by a red 
box whereas the grey box shows the position of the phosphopeptide identified in 
mammalian BiP (Gaut, 1997), which spans from Thr455 to Asp506 of Chlamydomonas 
BiP.  B, Amino acid sequence alignment of the phosphopeptide identified in 
Chlamydomonas BiP (from Glu504 to Lys525) with the corresponding region of BiP 
proteins from other organisms.  Cr, Chlamydomonas reinhardtii; Vc, Volvox carteri; Ot, 
Ostreococcus tauri; Ol, Ostreococcus lucimarinus; Msp, Micromonas sp. RCC299; Sl, 
Solanum lycopersicum; Nb, Nicotiana benthamiana; Vv, Vitis vinifera; Pt, Populus 
trichocarpa; Zm, Zea mays; Os, Oryza sativa; Gm, Glycine max; At, Arabidopsis 
thaliana; Pt, Physcomitrella patens; mBiP, Mus musculus.  C, Modeling of 
Chlamydomonas BiP1 based on the crystal structure of mammalian 70 kDa heat shock 
protein (3c7nA).  Conserved Thr520 was mapped onto the crystal structure.  Structure 
prediction was performed using the SWISS-MODEL bioinformatics tool and image was 
generated by iMol software.  ATPase and peptide-binding domains are shown in yellow 
and blue, respectively. 
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Figure 6.  Chlamydomonas BiP1 partially complements KAR2 function in a kar2-159 
ts mutant.  A, MS10 (wt) and kar2-159 strains transformed with empty plasmid or 
plasmids expressing Chlamydomonas BiP1, T520A, T520E or T520R proteins were 
streaked for single colonies.  Plates were incubated at the indicated temperatures for 3-4 
days.  B, MS10 (wt) and kar2-159 strain expressing the indicated Chlamydomonas BiP1 
proteins were grown at the permissive temperature of 25ºC and expression of BiP1 and 
endogenous KAR2 proteins in these cells were detected by western blot.  Precursor and 
mature forms of BiP1 are indicated.  Cr, soluble extract from Chlamydomonas cells 
grown in TAP medium.  50 μg of total protein were loaded per lane. 
 
Figure 7.  Relocalization of BiP in tunicamycin-treated cells.  Wild-type 
Chlamydomonas cells growing exponentially in acetate medium were treated with 500 
nM rapamycin (rap) or 5 μg/ml tunicamycin (tun) for 8 h.  Cells were collected and 
processed for IF microscopy analysis.  The signal recognized by the BiP antibody is 
shown in green.  DNA staining is shown in blue (DAPI). 
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Figure 1. Rapamycin treatment induces alterations on the threonine phosphorylation pattern in 
Chlamydomonas soluble extract.  A, Western blot analysis of Chlamydomonas soluble extracts 
with phosphoserine (P-Ser) and phosphothreonine (P-Thr) antibodies.  Log-phase wild-type 
cells were treated with 500 nM rapamycin (rap) or drug vehicle and samples were taken at the 
indicated times. Soluble extracts were fractionated by SDS-PAGE and analyzed by western 
blot.  The asterisk denotes the 70 kDa band detected with the P-Thr antibody.  B, Soluble 
extracts of Chlamydomonas cells treated (rap) or not (control) with 500 nM rapamycin for 8 
hours were resolved by 2D electrophoresis as described in Experimental Procedures.  Gels 
were stained with Coomassie Brilliant Blue (CBB) or processed for immunodetection with the 
phospho-threonine (P-Thr) antibody.  C, Enlarged images of box sections in 2D gels shown in 
panel B.  Arrow indicates spots whose mobility differs in untreated and rapamycin-treated cells.  
Numbers refer to spots where proteins have been identified by mass spectrometry (see Suppl. 
Table I for details).
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Figure 2. Rapamycin induces threonine phosphorylation of the BiP chaperone in its 
peptide-binding domain.  A, Phosphorylation time course of the 70 kDa protein following 
rapamycin treatment.  500 nM rapamycin or drug vehicle were added to wild-type (wt) or 
rapamycin-insensitive (rap2) Chlamydomonas cells and samples were collected at the 
indicated times.  Soluble extracts were fractionated by SDS-PAGE and analyzed by wes-
tern blotting probing with phosphothreonine (P-Thr), BiP and HSP70B specific antibodies. 
B, 2D western blot analysis of BiP and HSP70B.  Wild type Chlamydomonas cells were 
treated with 500 nM rapamycin for 12 hours (rap), heat shocked at 40ºC for 1 hour (HS) or 
remained untreated (control).  Soluble extracts were resolved by 2D electrophoresis as 
described in Experimental Procedures using pH 4-7 strips and gels were processed for 
immunodetection with phosphothreonine (P-Thr), BiP and HSP70B specific antibodies.
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Figure 3.  Inhibition of protein synthesis by rapamycin or cycloheximide induces BiP phos-
phorylation.  A, Time course of BiP phosphorylation following rapamycin and/or cycloheximi-
de treatment.  500 mM rapamycin (rap), 10 μg/ml cycloheximide (CHX) or both drugs simul-
taneously (CHX + rap) were added to wild-type Chlamydomonas cells and samples were 
taken at the indicated times.  Soluble extracts were fractionated by SDS-PAGE and analyzed 
by western blot probing with P-Thr or BiP specific antibodies.  B, Incorporation of 
[14C]arginine in Chlamydomonas cells.  Wild-type (wt) and rapamycin-insensitive (rap2) 
Chlamydomonas cells were treated with 500nM rapamycin for 6 hours (rap), 10 μg/ml 
cycloheximide for 30 min (CHX), or drug vehicle (C) and processed for the analysis of 
[14C]arginine incorporation as described in Experimental Procedures.  Values are represen-
ted in relation to the [14C]arginine incorporation detected in control, untreated cells and 
correspond to six independent determinations (*p<0.05, **p<0.01).  C, Effect of CHX and 
rapamycin on protein synthesis.  Chlamydomonas cultures were treated with 500 nM rapa-
mycin (triangles) or 10 μg/ml CHX (circles) or drug vehicle (squares) and samples were 
taken at different times for protein synthesis determination.  Data correspond to results from 
three independent experiments made in duplicate.
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Figure 4.  BiP dephosphorylation by ER stress-inducing agents.  BiP dephosphorylation by 
heat stress.  Chlamydomonas cells pretreated (B) or not (A) with 500 nM rapamycin (rap) for 
12 hours were subjected to heat stress at 40ºC and samples were taken at the indicated 
times.  Soluble extracts were fractionated by SDS-PAGE and analyzed by western blot probing 
with P-Thr and BiP specific antibodies.  C, BiP dephosphorylation by tunicamycin treatment.  
Chlamydomonas cells were treated with 500 nM rapamycin (rap), 5 μg/ml tunicamycin (tun), or 
first treated with rapamycin (rap, lane 8) and then with tunicamycin (rap tun, lane 9). Samples 
were taken at the indicated times and soluble extracts were processed and analyzed by wes-
tern blot.
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Figure 5.  Identification of a phosphopeptide in Chlamydomonas BiP.  A, Schematic repre-
sentation of the BiP protein and identification of a phosphopeptide in the peptide-binding 
domain.  The scheme shows the ATPase and peptide-binding domains of BiP.  The position 
of the phosphopeptide identified in Chlamydomonas is indicated by a red box whereas the 
grey box shows the position of the phosphopeptide identified in mammalian BiP (Gaut, 
1997), which spans from Thr455 to Asp506 of Chlamydomonas BiP.  B, Amino acid sequen-
ce alignment of the phosphopeptide identified in Chlamydomonas BiP (from Glu504 to 
Lys525) with the corresponding region of BiP proteins from other organisms.  Cr, Chlamydo-
monas reinhardtii; Vc, Volvox carteri; Ot, Ostreococcus tauri; Ol, Ostreococcus lucimarinus; 
Msp, Micromonas sp. RCC299; Sl, Solanum lycopersicum; Nb, Nicotiana benthamiana; Vv, 
Vitis vinifera; Pt, Populus trichocarpa; Zm, Zea mays; Os, Oryza sativa; Gm, Glycine max; 
At, Arabidopsis thaliana; Pt, Physcomitrella patens; mBiP, Mus musculus.  C, Modeling of 
Chlamydomonas BiP1 based on the crystal structure of mammalian 70 kDa heat shock 
protein (3c7nA).  Conserved Thr520 was mapped onto the crystal structure.  Structure 
prediction was performed using the SWISS-MODEL bioinformatics tool and image was 
generated by iMol software.  ATPase and peptide-binding domains are shown in yellow and 
blue, respectively.
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Figure 6.  Chlamydomonas BiP1 partially complements KAR2 function in a kar2-159 ts 
mutant.  A, MS10 (wt) and kar2-159 strains transformed with empty plasmid or plasmids 
expressing Chlamydomonas BiP1, T520A, T520E or T520R proteins were streaked for 
single colonies.  Plates were incubated at the indicated temperatures for 3-4 days.  B, 
MS10 (wt) and kar2-159 strain expressing the indicated Chlamydomonas BiP1 proteins 
were grown at the permissive temperature of 25ºC and expression of BiP1 and endoge-
nous KAR2 proteins in these cells were detected by western blot.  Precursor and mature 
forms of BiP1 are indicated.  Cr, soluble extract from Chlamydomonas cells grown in TAP 
medium.  50 μg of total protein were loaded per lane.
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Figure 7.  Relocalization of BiP in tunicamycin-treated cells.  Wild-type Chlamydomonas 
cells growing exponentially in acetate medium were treated with 500 nM rapamycin (rap) or 
5 μg/ml tunicamycin (tun) for 8 h.  Cells were collected and processed for IF microscopy 
analysis.  The signal recognized by the BiP antibody is shown in green.  DNA staining is 
shown in blue (DAPI).
